Jian Kang

9PUBLICATIONS
27CO-AUTHORS
Radiation therapyMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursCell metabolism
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Aug 14, 2025
Ribosome Biogenesis and Function in Cancer: From Mechanisms to Therapy.

Kezia Gitareja, Shalini S Chelliah, Elaine Sanij

|Jun 27, 2022
Cystathionine-β-synthase is essential for AKT-induced senescence and suppresses the development of gastric cancers with PI3K/AKT activation.

Haoran Zhu, Keefe T Chan, Xinran Huang

|Oct 04, 2021
A Novel Mechanism of Endoplasmic Reticulum Stress- and c-Myc-Degradation-Mediated Therapeutic Benefits of Antineurokinin-1 Receptor Drugs in Colorectal Cancer.

Yue Shi, Xi Wang, Yueming Meng

|Sep 03, 2021
A Histone Deacetylase Inhibitor, Panobinostat, Enhances Chimeric Antigen Receptor T-cell Antitumor Effect Against Pancreatic Cancer.

Aesha I Ali, Minyu Wang, Bianca von Scheidt

|Jan 29, 2021
Impaired ribosome biogenesis checkpoint activation induces p53-dependent MCL-1 degradation and MYC-driven lymphoma death.

Ana Domostegui, Suresh Peddigari, Carol A Mercer

|Nov 11, 2020
The RNA polymerase I transcription inhibitor CX-5461 cooperates with topoisomerase 1 inhibition by enhancing the DNA damage response in homologous recombination-proficient high-grade serous ovarian cancer.

Shunfei Yan, Jiachen Xuan, Natalie Brajanovski

Pageof 2

Frequent Collaborators

4 joint publications

Richard B Pearson

3 joint publications

Keefe T Chan

3 joint publications

Elaine Sanij

2 joint publications

Eric P Kusnadi